Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Garrison

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neurology|September 1, 1984
Estimating physician requirements for neurology: a needs-based approachL P Garrison, M A Bowman, E B Perrin
Pharmacoeconomics|October 5, 1993
Strategic use of pharmacoeconomic research in early drug development and global pricingK Clemens, L P Garrison, A Jones, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Cost-effectiveness of repeat medical procedures: kidney transplantation as an exampleJ C Hornberger, J H Best, L P Garrison
JAMA|November 18, 1983
Estimates of physician requirements for 1990 for the specialties of neurology, anesthesiology, nuclear medicine, pathology, physical medicine and rehabilitation, and radiology. A further application of the GMENAC methodologyM A Bowman, J M Katzoff, L P Garrison, et al.
Diabetes, Obesity & Metabolism|November 15, 2011
The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic reviewJ H Best, K Lavillotti, M B DeYoung, et al.
AANNT Journal|October 1, 1983
The use of rehabilitation services by patients with chronic renal failure: results from the National Kidney Dialysis and Kidney Transplantation StudyR W Evans, D L Manninen, L P Garrison, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007J T Cross, D L Veenstra, J S Gardner, et al.
JAMA|April 11, 1986
Donor availability as the primary determinant of the future of heart transplantationR W Evans, D L Manninen, L P Garrison, et al.
Medical Care|January 1, 1984
Interspecialty variation in office-based careH P Greenwald, M L Peterson, L P Garrison, et al.
The New England Journal of Medicine|February 28, 1985
The quality of life of patients with end-stage renal diseaseR W Evans, D L Manninen, L P Garrison, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neurology|September 1, 1984
Estimating physician requirements for neurology: a needs-based approachL P Garrison, M A Bowman, E B Perrin
Pharmacoeconomics|October 5, 1993
Strategic use of pharmacoeconomic research in early drug development and global pricingK Clemens, L P Garrison, A Jones, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Cost-effectiveness of repeat medical procedures: kidney transplantation as an exampleJ C Hornberger, J H Best, L P Garrison
JAMA|November 18, 1983
Estimates of physician requirements for 1990 for the specialties of neurology, anesthesiology, nuclear medicine, pathology, physical medicine and rehabilitation, and radiology. A further application of the GMENAC methodologyM A Bowman, J M Katzoff, L P Garrison, et al.
Diabetes, Obesity & Metabolism|November 15, 2011
The effects of exenatide bid on metabolic control, medication use and hospitalization in patients with type 2 diabetes mellitus in clinical practice: a systematic reviewJ H Best, K Lavillotti, M B DeYoung, et al.
AANNT Journal|October 1, 1983
The use of rehabilitation services by patients with chronic renal failure: results from the National Kidney Dialysis and Kidney Transplantation StudyR W Evans, D L Manninen, L P Garrison, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007J T Cross, D L Veenstra, J S Gardner, et al.
JAMA|April 11, 1986
Donor availability as the primary determinant of the future of heart transplantationR W Evans, D L Manninen, L P Garrison, et al.
Medical Care|January 1, 1984
Interspecialty variation in office-based careH P Greenwald, M L Peterson, L P Garrison, et al.
The New England Journal of Medicine|February 28, 1985
The quality of life of patients with end-stage renal diseaseR W Evans, D L Manninen, L P Garrison, et al.
Pageof 3